markets Gland Pharma shares: Proven insights on market rally potential Russell ClarksonNovember 9, 20260 Gland Pharma shares are hitting a 52-week high; explore if the rally will continue after a significant YTD rise.
markets Ashok Leyland shares: A Proven Boost in Stock Value Russell ClarksonNovember 5, 20260 Ashok Leyland shares jumped over 10% recently, marking a significant gain. Discover what factors contributed to this surge.
markets US midterm election results spark a Smart Rally Russell ClarksonNovember 5, 20260 US midterm election results have led to a significant rally on Dalal Street, boosting investor confidence.
IPO News Milky Mist Dairy IPO: Proven 14.29% Listing Gain Ahead Russell ClarksonNovember 4, 20260 Milky Mist Dairy IPO suggests a promising 14.29% listing gain for investors, indicating strong market interest.
Crypto News Bitcoin ETF outflows: What are the worst trends? Russell ClarksonNovember 3, 20260 Bitcoin ETF outflows have surged recently, raising concerns among investors. What does this mean for the future?
banking Investors Rethink Bonds: What’s the Right Strategy Now? Russell ClarksonNovember 2, 20260 Investors rethink bonds as rates turn and debt follows. Discover smart strategies to navigate this changing market.
Crypto News Bitcoin Spot ETFs: Worst Outflows Recorded This Year? Russell ClarksonNovember 1, 20260 Bitcoin Spot ETFs have seen record outflows of $643M recently, raising concerns among investors.
Business Agios Pharmaceuticals Earnings: Is It the Best Time to Invest? Russell ClarksonOctober 30, 20260 Agios Pharmaceuticals earnings could surprise investors this Q3. Discover what analysts predict and how it may impact your investments.
markets Sensex Nifty recovery: Is the worst finally over? Russell ClarksonOctober 30, 20260 Sensex Nifty recovery shows positive signs. Is the worst finally over for investors?
markets Defence stock Raymond shows clear retracement amid trends Russell ClarksonOctober 28, 20260 Defence stock Raymond has retraced after a jump, reflecting weak trends on D-Street. Check the target and potential upside.